Metabolism and biomarkers of Vitamin D

References

• Holick MF. Chapter 2: Photobiology of Vitamin D. In: Feldman D, Pike JW, Adams M, editors. Vitamin D. 3rd Edition. Academic Press 2011. pp. 13–22.
   Google Scholar
• Bouillon R. Chapter 5: The Vitamin D Binding Protein DBP. In: Feldman D, Pike JW, Adams M, editors. Vitamin D. 3rd Edition. Academic Press 2011. pp. 57–72.
   Google Scholar
• Jones G, Strugnell SA, DeLuca HF. Current understanding of the molecular actions of vitamin D. Physiol. Rev. 1998; 78:1193–1231.
   PubMed Web of Science ®Google Scholar
• Cheng JB, Motola DL, Mangelsdorf DJ, Russell DW. De-orphanization of cytochrome P450 2R1: a microsomal vitamin D 25-hydroxylase. J Biol Chem 2003;278: 38084–93.
   PubMed Web of Science ®Google Scholar
• Jones G, Byford V, West S, Masuda S, Ibrahim G, Kaufmann M, Knutson J, Strugnell S, Mehta R. Hepatic Activation & Inactivation of Clinically-Relevant Vitamin D Analogs and Prodrugs. Anticancer Research. 2006;26:2589–2596.
   Google Scholar
• Strushkevich N, Usanov SA, Plotnikov AN, Jones G, Park H-W. Structural Analysis of CYP2R1 in complex with vitamin D3. J Mol Biol 2008;380: 95–106.
   PubMed Web of Science ®Google Scholar
• Cheng JB, Levine MA, Bell NH, Mangelsdorf DJ, Russell DW. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc Natl Acad Sci USA 2004;101:7711–5.
   PubMed Web of Science ®Google Scholar
• Wang TJ, Zhang F, Richards JB . Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 2010;376:180–8.
   PubMed Web of Science ®Google Scholar
• Ahn J, Yu K, Stolzenberg-Solomon R, Simon KC, McCullough ML, Gallicchio L, Jacobs EJ, Ascherio A, Helzlsouer K, Jacobs KB, Li Q, Weinstein SJ, Purdue M, Virtamo J, Horst R, Wheeler W, Chanock S, Hunter DJ, Hayes RB, Kraft P, Albanes D. Genome-wide association study of circulating vitamin D levels. Hum Mol Genet 2010;19:2739–45.
   PubMed Web of Science ®Google Scholar
• Prosser DE, Jones G. Enzymes involved in the activation and inactivation of vitamin D. Trends in Biochemical Sciences 2004;29:664–73.
   PubMed Web of Science ®Google Scholar
• DeLuca HF. Vitamin D: the vitamin and the hormone. Fed Proc 1974;33:2211–9.
   PubMedGoogle Scholar
• St-Arnaud R, Messerlian S, Moir JM, Omdahl JL, Glorieux FH. The 25-hydroxyvitamin D 1-α-hydroxylase gene maps to the pseudovitamin D-deficiency rickets (PDDR) disease locus. J Bone Miner Res 1997;12:1552–1559.
   Google Scholar
• Martinez I, Saracho R, Montenegro J, Llach F (1996) A deficit of calcitriol synthesis may not be the initial factor in the pathogenesis of secondary hyperparathyroidism Nephrol Dial Transplant 1996;11(Suppl 3):22–8.
   Google Scholar
• Jones G, Prosser DE. Chapter 3: The Activating Enzymes of Vitamin D Metabolism (25- and 1α-hydroxylases). In: Feldman D, Pike W, Adams J, editors “Vitamin D” 3rd Edition. San Diego: Elsevier, 2011. pp. 23–42.
   Google Scholar
• Fraser D, Kooh SW, Kind HP, Holick MF, Tanaka Y, DeLuca HF. Pathogenesis of hereditary vitamin-D-dependent rickets. An inborn error of vitamin D metabolism involving defective conversion of 25-hydroxyvitamin D to 1α,25-dihydroxyvitamin D. N Engl J Med 1973;289:817–22.
   PubMed Web of Science ®Google Scholar
• Panda DK, Miao D, Tremblay ML, Sirois J, Farookhi R, Hendy GN, Goltzman D. Targeted ablation of the 25-hydroxyvitamin D 1α-hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction Proc Nat Acad Sci 2001;98:7498–7503.
   PubMed Web of Science ®Google Scholar
• Dardenne O, Prud'homme J, Arabian A, Glorieux FH, St-Arnaud R. Targeted inactivation of the 25-hydroxyvitamin D3-1α-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets Endocrinology 2001;142:3135–41.
   Google Scholar
• Hewison M, Adams J. Chapter 45: “Extrarenal 1α-hydroxylase”. In: “Vitamin D” 3nd Edition. Eds Feldman D, Pike W, Adams JS. Academic Press, San Diego; 2011. pp. 777–804.
   Google Scholar
• Adams JS, Sharma OP, Gacad MA, Singer FR. Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis. J Clin Invest 1983;72:1856–60.
   PubMed Web of Science ®Google Scholar
• Makin G, Lohnes D, Byford V, Ray R, Jones G. Target cell metabolism of 1,25-dihydroxyvitamin D3 to calcitroic acid. Evidence for a pathway in kidney and bone involving 24-oxidation. Biochem J 1989;262: 173–180.
   PubMed Web of Science ®Google Scholar
• Reddy GS, Tserng K-Y. Calcitroic acid, end product of renal metabolism of 1,25-dihydroxyvitamin D3 through C-24 oxidation pathway. Biochemistry 1989;28:1763–9.
   PubMed Web of Science ®Google Scholar
• Jones G, Prosser DE, Kaufmann M. 25-hydroxyvitamin D3-24-hydroxylase (CYP24A1): Its important role in the degradation of vitamin D. Arch Biochem Biophys, epub Nov 12, 2011.
   Google Scholar
• St-Arnaud R. CYP24A1-deficient mice as a tool to uncover a biological activity for vitamin D metabolites hydroxylated at position 24. J. Steroid Biochem Mol Biol 2010;121: 254–256.
   Google Scholar
• Schlingmann KP, Kaufmann M, Weber S, Irwin A, Goos C, Wassmuth A, John U, Misselwitz J, Klaus G, Kuwertz-Broking E, Fehrenbach H, Wingen AM, Guran T, Akcay T, Hoenderop JG, Bindels RJ, Prosser DE, Jones G, Konrad M. Mutations of CYP24A1 and Idiopathic Infantile Hypercalcemia. New Engl J Med 2011;365: 410–421.
   PubMed Web of Science ®Google Scholar
• St-Arnaud R. Targeted inactivation of vitamin D hydroxylases in mice. Bone 1999;25:127–129.
   Google Scholar
• Tangpricha V, Flanagan JN, Whitlatch LW, Tseng CC, Chen TC, Holt PR, Lipkin MS, Holick MF. 25-hydroxyvitamin D-1α-hydroxylase in normal and malignant colon tissue. Lancet. 2001;357:1673–4.
   PubMed Web of Science ®Google Scholar
• Chen TC, Wang L, Whitlatch LW, Flanagan JN, Holick MF. Prostatic 25-hydroxyvitamin D-1α-hydroxylase and its implication in prostate cancer. J. Cell Biochem. 2003;88:315–22.
   PubMed Web of Science ®Google Scholar
• Bises G, Kállay E, Weiland T, Wrba F, Wenzl E, Bonner E, Kriwanek S, Obrist S, Cross HS. 25-hydroxyvitamin D3-1α-hydroxylase expression in normal and malignant human colon. J. Histochem. Cytochem. 2004;52:985–9.
   Google Scholar
• Friedrich M, Diesing D, Cordes T, Fischer D, Becker S, Chen TC, Flanagan JN, Tangpricha V, Gherson I, Holick MF, Reichrath J. Analysis of 25-hydroxyvitamin D3-1α-hydroxylase in normal and malignant breast tissue. Anticancer Res. 2006;26:2615–20.
   PubMed Web of Science ®Google Scholar
• Judd SE, Tangpricha V. Vitamin D deficiency and risk for cardiovascular disease. Am J Med Sci 2009;338:40–4.
   PubMed Web of Science ®Google Scholar
• Haussler MR, Haussler CA, Whitfield GK, . The nuclear vitamin D receptor controls the expression of genes encoding factors which feed the “Fountain of Youth” to mediate healthful aging. J Steroid Biochem Mol Biol. 2010;121:88–97.
   PubMed Web of Science ®Google Scholar
• Dietary Reference Intakes for Vitamin D and Calcium. Institute of Medicine of the National Academy of Sciences, The National Academies Press, Washington DC 2011. pp. 1–1115.
   Google Scholar
• Holick MF. Vitamin D deficiency N Engl J Med 2007; 357:266–81.
   PubMed Web of Science ®Google Scholar
• Dowd DR, MacDonald PN. Chapter 10: Coregulators of VDR-Mediated Gene Expression. In: “Vitamin D” 3nd Edition. Eds Feldman D, Pike W, Adams JS. Academic Press, San Diego; 2011. pp. 193–210.
   Google Scholar
• White JH. Profiling 1,25-dihydroxyvitamin D3-regulated gene expression by microarray analysis. J Steroid Biochem Mol Biol. 2004;89–90:239–44.
   Google Scholar
• Zella LA, Meyer MB, Nerenz RD, Pike JW. The enhanced hypercalcemic response to 20-epi-1,25-dihydroxyvitamin D3 results from a selective and prolonged induction of intestinal calcium-regulating genes. Endocrinology 2009;150:3448–56.
   Google Scholar
• Matthews D, LaPorta E, Zinser GM, Narvaez CJ, Welsh J. Genomic vitamin D signaling in breast cancer: Insights from animal models and human cells. J Steroid Biochem Mol Biol. 2010;121:362–7.
   PubMedGoogle Scholar
• Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, Luderer HF, Lieben L, Mathieu C, Demay M. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 2008;29:726–76.
   PubMed Web of Science ®Google Scholar
• Hendy GN, Kremer R, Goltzman D. Chapter 33: “Contributions of Genetically modified mouse models to understanding the physiology and pathophysiology of the 25-hydroxyvitamin D-1α-hydroxylase (1α(OH)ase) and the vitamin D receptor (VDR). In: “Vitamin D” 3nd Edition. Eds Feldman D, Pike W, Adams JS. Academic Press, San Diego, 2011. pp. 583–607.
   Google Scholar
• Jones G. Pharmacokinetics of Vitamin D Toxicity. Amer J Clin Nutr 2008;88(suppl):582S–586S.
   PubMed Web of Science ®Google Scholar
• DeLuca HF, Prahl JM, Plum LA. 1,25-Dihydroxyvitamin D is not responsible for toxicity caused by vitamin D or 25-hydroxyvitamin D. Arch Biochem Biophys. 2011;505: 226–30.
   PubMed Web of Science ®Google Scholar
• Strathmann FG, Laha TJ, Hoofnagle AN. Quantification of 1α,25-dihydroxy vitamin D by immunoextraction and liquid chromatography-tandem mass spectrometry. Clin Chem. 2011; 57:1279–85.
   PubMed Web of Science ®Google Scholar
• Jones G (2007) Expanding role for vitamin D in chronic kidney disease: Importance of blood 25(OH)D levels & extra-renal 1α-hydroxylase in the classical and non-classical actions of 1α,25-dihydroxyvitamin D3. Seminars in Dialysis 20:316–324.
   Google Scholar
• Jones G. Editorial: Why Dialysis Patients need combination therapy with cholecalciferol and a calcitriol analog. Seminars in Dialysis 2010;23:239–43.
   PubMed Web of Science ®Google Scholar
• Jones G, Horst RL, Carter G, Makin HLJ. Contemporary Diagnosis and Treatment of Vitamin D-related Disorders. J Bone Mineral Res 2007;22 (Suppl 2):V11–V15.
   PubMedGoogle Scholar
• Carter G. 25-hydroxyvitamin D assays: are they fit for the purpose. Proceedings of IFCC-WorldLab Meeting Berlin, May 2011. Berlin: DeGruyter, in press.
   Google Scholar
• Ross AC, Manson JE, Taylor CL, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Mayne ST, Rosen CJ, Shapses S. The 2011 IOM Report on Vitamin D and Calcium: What Physicians Need to Know. J Clin Endocrinol Metab. 2011;96:53–58.
   PubMed Web of Science ®Google Scholar